Switch to:
More From Other Websites
Halozyme Therapeutics, Inc. – Value Analysis (NASDAQ:HALO) : April 24, 2017 Apr 24 2017
Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HALO-US : April... Apr 21 2017
If You Don't Buy These 5 Stocks Before Their Looming Breakout, It's Your Loss Apr 20 2017
Halozyme To Host First Quarter 2017 Financial Results Conference Call Apr 10 2017
Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US : April... Apr 06 2017
Halozyme's PEGPH20 Increases Immune Response and Effectiveness of Immunotherapies in Preclinical... Apr 03 2017
Rosetta Genomics and Halozyme Therapeutics: Wait for Better News Mar 31 2017
Here's Why Halozyme Therapeutics, Inc Is Falling Mar 30 2017
Biotech Premarket Movers: Halozyme, Omeros, Aralez Mar 30 2017
Halozyme Provides Update On SWOG Collaborative Group Clinical Study Mar 30 2017
ETFs with exposure to Halozyme Therapeutics, Inc. : March 30, 2017 Mar 29 2017
FDA Advisory Committee Provides Unanimous Recommendation For Subcutaneous Rituximab Coformulated... Mar 29 2017
Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Mar 02 2017
5 Small-Cap Biotech Stocks to Buy in March Mar 02 2017
Edited Transcript of HALO earnings conference call or presentation 28-Feb-17 9:30pm GMT Mar 01 2017
Halozyme Therapeutics reports 4Q loss Feb 28 2017
Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results Feb 28 2017
Why Halozyme Therapeutics (HALO) Might Surprise This Earnings Season Feb 27 2017
Halozyme Therapeutics To Present At Upcoming Healthcare Conferences Feb 23 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK